Quiet on the insider front: nobody at Lexaria Bioscience Corp. bought or sold LEXX shares at market prices this past year.
31 investment managers listed LEXX in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | BUNKA CHRISTOPHER | Director | Buy | 15,600 | $0.92 | $14K | SEC |
| Jul 30, 2025 | BUNKA CHRISTOPHER | Director | Buy | 11,900 | $0.91 | $11K | SEC |
| Jul 30, 2025 | McKechnie William Edward | Director | Buy | 5,000 | $0.91 | $5K | SEC |
| Jul 30, 2025 | DOCHERTY JOHN MARTIN | President | Buy | 5,376 | $0.93 | $5K | SEC |
| Jul 30, 2025 | Carle Vanessa | Officer | Buy | 750 | $0.91 | $682 | SEC |
| Jul 30, 2025 | CHRISTOPHER RICHARD | CEO | Buy | 15,000 | $0.91 | $14K | SEC |
| Dec 3, 2024 | CHRISTOPHER RICHARD | CEO | Buy | 27,172 | $2.47 | $67K | SEC |
| Dec 3, 2024 | CHRISTOPHER RICHARD | CEO | Buy | 22,828 | $2.24 | $51K | SEC |
| Aug 13, 2024 | TURKEL CATHERINE C. | Director | Buy | 1,600 | $3.13 | $5K | SEC |
| Aug 1, 2024 | Carle Vanessa | Officer | Sell | 2,567 | $4.00 | $10K | SEC |
| Feb 27, 2023 | TURKEL CATHERINE C. | Director | Buy | 1,500 | $2.84 | $4K | SEC |
There were no open-market insider trades in LEXX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
31 investment managers reported holding LEXX in SEC Form 13F filings for Q2 2026.
No congressional trades in LEXX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).